Stockscreener 앱 받기
360.37
0.56%
1.955
전일 마감가:
$358.41
열려 있는:
$385
하루 거래량:
1.16M
Relative Volume:
1.39
시가총액:
$25.46B
수익:
$3.22B
순이익/손실:
$542.70M
주가수익비율:
48.17
EPS:
7.4805
순현금흐름:
$458.00M
1주 성능:
-0.56%
1개월 성능:
+7.14%
6개월 성능:
+52.29%
1년 성능:
+58.55%
1일 변동 폭
$351.18
$386.00
1주일 범위
$345.70
$386.00
52주 변동 폭
$223.83
$386.00
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
360.37 | 25.32B | 3.22B | 542.70M | 458.00M | 7.4805 |
ISRG
Intuitive Surgical Inc
|
331.70 | 122.06B | 11.03B | 3.16B | 2.83B | 8.7254 |
BDX
Becton Dickinson Co
|
153.09 | 42.20B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.14 | 32.85B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.59 | 31.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
190.65 | 27.98B | 5.54B | 1.52B | 1.74B | 10.37 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 개시 | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 개시 | Barclays | Equal Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
West Pharmaceutical Services (WST) Reports Strong Q2 2026 Earnin - GuruFocus
Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 17, 2026. - marketscreener.com
West Pharmaceutical CEO Highlights GLP-1 And Biologics Momentum - Benzinga
West Pharma raises profit forecast on strong demand for injectable drug components - Reuters
West Pharmaceutical Services, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Earnings call transcript: West Pharmaceutical beats Q2 2026 estimates, lifts outlook - Investing.com
West Pharmaceutical (WST) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Full Transcript: West Pharmaceutical Servs Q2 2026 Earnings Call - Benzinga
Why is West Pharmaceutical Services stock surging today? - Investing.com
West Pharmaceutical Services Releases Q2 2026 Financial Results - AlphaStreet
Is West Pharmaceutical Services Inc (WST) Undervalued After Q2 E - GuruFocus
West Pharmaceutical Services (NYSE:WST) Beats Expectations in Strong Q2 CY2026, Stock Soars - Yahoo Finance
Form 8-K WEST PHARMACEUTICAL SERV For: Jul 23 - StreetInsider
West Pharmaceutical Services (WST) Q2 Earnings and Revenues Top Estimates - Yahoo Finance
West Pharma stock rises 6% on strong earnings beat and raised guidance - Investing.com UK
West Pharmaceutical raises FY2026 sales and EPS guidance - scanx.trade
West Pharmaceutical raises annual profit forecast on strong demand for injectable drug components - marketscreener.com
(WST) West Pharmaceutical Services, Inc. Expects Q3 Revenue Range $820.0M$835.0M - marketscreener.com
West Pharmaceutical Services earnings beat by $0.29, revenue topped estimates - Investing.com Canada
(WST) West Pharmaceutical Services Expects Full Year 2026 Adjusted EPS Range $8.85$9.05, vs. FactSet Est of $8.62 - marketscreener.com
Earnings Flash (WST) West Pharmaceutical Services, Inc. Reports Q2 Revenue $872.3M, vs. FactSet Est of $840.0M - marketscreener.com
(WST) West Pharmaceutical Services Expects Full Year 2026 Net Sales Range $3.35B$3.38B vs. FactSet Est of $3.33B - marketscreener.com
Earnings Flash (WST) West Pharmaceutical Services, Inc. Posts Q2 Adjusted EPS $2.37 per Share, vs. FactSet Est of $2.08 - marketscreener.com
West Pharmaceutical Services Inc (WST) Earnings: FY Adjusted EPS Forecast Raised Following Strong Q2 Results - Smartkarma
West Pharmaceutical: Q2 Earnings Snapshot - KTVB
West Reports Second-Quarter 2026 Results - PR Newswire
West Pharmaceutical stock holds steady on 2026 earnings context - Ad-hoc-news.de
West Pharma stock rises nearly 33% YTD on stron... - Pluang
West Pharmaceutical Services, Inc. (WST) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Q2 2026 earnings preview - msn.com
West Pharmaceutical Services (WST) Q2 Earnings Report Preview: What To Look For - Yahoo Finance
West Pharmaceutical Services IncUS Datawatch: Bill Gates' top 5 winning stocks of 2026; surged up to 55% YTD - The Economic Times
Investors brace for West Pharmaceutical earnings after Q1 beat By Investing.com - Investing.com Australia
West (WST) Stock Looks Pricey With Little Room Above Fair Value - Yahoo Finance
West Pharmaceutical Services declares $0.22 quarterly dividend By Investing.com - Investing.com Australia
West Pharmaceutical Services Keeps Quarterly Dividend at $0.22 per Share, Payable Aug. 5 to Holders of Record July 29 - marketscreener.com
West Pharmaceutical Services declares $0.22 quarterly dividend - Investing.com
West Declares Quarterly Dividend - PR Newswire
WST Likely to Beat Q2 Earnings Estimates: How to Play the Stock? - TradingView
Curious about West Pharmaceutical (WST) Q2 Performance? Explore Wall Street Estimates for Key Metrics - Yahoo Finance
West Pharmaceutical stock trades near record levels as recent earnings highlight margin strength - Ad-hoc-news.de
ETFs Investing in West Pharmaceutical Services, Inc. Stocks - TradingView
West Pharmaceutical Services Inc. stock underperforms Monday when compared to competitors - MarketWatch
Stephens Adjusts West Pharmaceutical Services Price Target to $410 From $360, Maintains Overweight Rating - marketscreener.com
West Pharmaceutical Services (WST) Q2 2026 Preview: EPS Est. $2.08, Reports July 23 - AlphaStreet
West Pharmaceutical stock trades steady as recent earnings and innovation investments shape outlook - Ad-hoc-news.de
Reasons to add West Pharmaceutical stock to your portfolio now - MSN
West Pharmaceutical stock trades steady as recent earnings highlight resilient demand and margin pre - Ad-hoc-news.de
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch
ISRG Q2 Earnings Beat Estimates, Stock Falls on Slow Procedure Growth - TradingView
West Pharmaceutical stock trades near record levels as recent earnings and guidance underpin valuati - Ad-hoc-news.de
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
1.02%
자본화:
|
볼륨(24시간):